In Brief: Fuisz Technologies
This article was originally published in The Tan Sheet
Executive Summary
Fuisz Technologies: Enters into agreement with Bayer Consumer Care Division for development of an undisclosed OTC drug "using one of Fuisz' proprietary rapid dissolve dosage forms." The company also is developing an EZ Chew version of an undisclosed SmithKline Beecham OTC product ("The Tan Sheet" Aug. 5, In Brief) and has a long-standing agreement with Whitehall-Robins for a "major" OTC ("The Tan Sheet" Aug. 19, p. 7)...